Sunday, 25 September 2022
Home
About Us
Equity, Diversity, and Inclusion
History
Faculty and Staff
Clinics
UCLA Dementia and Memory Disorders Clinic at UCLA Medical Center, Westwood
Memory Disorders Clinic at Olive View-UCLA Medical Center
Contact Us
Patients & Caregivers
Coronavirus (COVID-19)
Aducanumab
About Alzheimer's Disease
About Non-Alzheimer Dementias
Information for New Patients
Find A Specialist
Physicians
Nurse Practitioners
Caregiver Support Groups
Q&A About Clinical Trials
Brain Donation Program
Helpful Links
Health Professionals
Referring a Patient
CADC ACCT-AD
Education
Latest News
Current Newsletter
Newsletter Archives
Newsletter Sign-Up Form
Calendar
Community Calendar
Research
Clinical Research
Recruiting Trials
Active Trials/Not Recruiting
Potential Participant Pool
Basic Research
Drug Research
Research Programs
UCLA-Easton Center
CADC
Vossel Lab
Kagan Clinical Trials Program
Jim Easton Consortium
Donate
Home
Research
Basic Research
Basic Research
Preventing the Accumulation of Amyloid-β and Tau in Alzheimer's Disease (AD)
COMPLETED: Studying the Physical Chemistry of Amyloid-β Aggregation
Studying the Biology of Alzheimer's Disease (AD) using Scientific Models
About
Us
Equity, Diversity, and Inclusion
History
Faculty and Staff
Clinics
Donate
Contact Us
Login/ Logout
Patients
& Caregivers
COVID-19
Aducanumab
About Alzheimer's Disease
About Non-Alzheimer's Dementias
Information for New Patients
Find A Doctor
Q&A About Clinical Trials
Caregiver Support Groups
Brain Donation Program
Helpful Links
Health
Professionals
Referring A Patient
CADC ACCT-AD
Education
Latest News
Current Newsletter
Newsletter Archives
Newsletter Sign-Up Form
Calendar
Research
Clinical Research
Basic Research
Drug Research
Research
Programs
UCLA-Easton Center
CADC
Vossel Lab
Kagan Clinical Trials Program
Jim Easton Consortium for Alzheimer’s Drug Discovery and Biomarker Development
